Other Information
−Removed: During the three months ended September 30, 2023, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in the SEC’s rules).
−Removed: Incorporated by Reference
−Removed: Number Exhibit Description Form Date Number Filed Herewith
+Added: During the three months ended March 31, 2024, one of our officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in the SEC’s rules).
+Added: The material terms of the Rule 10b5-1 trading arrangement are described below:
+Added: Name and Title Action Taken Type of Trading Arrangement Nature of Trading Arrangement Duration of Trading Arrangement Number of Securities
+Added: Jon Congleton , Chief Executive Officer and Director
+Added: Adoption January 30, 2024
+Added: Trading plan intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c)
+Added: Sale of the Company’s common stock pursuant to the terms of the plan June 11, 2024 through December 31, 2025
+Added: __________________
+Added: (1) The executive’s Rule 10b5-1 trading arrangement provides for the sale of up to 479,389 shares of common stock subject to a restricted stock award granted to Mr.
+Added: Congleton that vests ratably over time.
+Added: Number Incorporated by Reference Filed Herewith
+Added: Exhibit Description Form Date Number
3.1 Amended and Restated Certificate of Incorporation
2 unchanged sentences
8-K 2/14/23 3.2
+Added: Form of Pre-Funded Warrant
+Added: Securities Purchase Agreement, dated February 7, 2024, by and between the Registrant and each of the purchasers party thereto
+Added: ATM Equity Offering Sales Agreement, dated March 21, 2024, by and among the Registra nt , BofA Securities, Inc.
+Added: and Evercore Group L.L.C.
+Added: S-3 3/21/24 1.2
31.1 Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
15 unchanged sentences
MINERALYS THERAPEUTICS, INC.
−Removed: November 7, 2023 By:
+Added: May 9, 2024 By:
/s/ Jon Congleton
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 7, 2023 By:
+Added: May 9, 2024 By:
/s/ Adam Levy
−Removed: Chief Financial Officer, Chief Business Officer, and Secretary
+Added: Chief Financial Officer and Secretary
(Principal Financial Officer;
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.